Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LifeStance Health Group, Inc.LFST · Entity 3936 | Chief Development Officer | June 11, 2024 | June 13, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LifeStance Health Group, Inc.
Report date June 11, 2024 · Filed June 13, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,650,571 |
Reported balance
After 2024-06-11 transaction · row 1
1 source rowRow 1 · 2024-06-11 · Sale · Disposed 85,093 · Balance 4,650,571 F1: Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 11, 2024 Filed Jun 13, 2024 16:48 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | SaleCommon Stock | 85,093 | $5.53 | $470,564.29 |
DisclosureSEC source: 0000950170-24-073100 · ownership.xml · nonDerivative · entry 1 Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,650,571 F1 · kind: Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| April 01, 2024 Filed Apr 19, 2024 16:27 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | SaleCommon Stock | 9,688 | $5.93 | $57,449.84 |
DisclosureSEC source: 0000950170-24-046030 · ownership.xml · nonDerivative · entry 1 Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,735,664 F1 · kind: Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| March 14, 2024 Filed Mar 18, 2024 17:11 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | SaleCommon Stock | 44,540 | $6.33 | $281,938.20 |
DisclosureSEC source: 0000950170-24-032920 · ownership.xml · nonDerivative · entry 1 Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,745,352 F1 · kind: Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 21:52 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | GrantCommon Stock | 89,586 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-030466 · ownership.xml · nonDerivative · entry 2 Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,789,892 F2 · shares: Represents performance-based restricted stock units previously granted to the Reporting Person, which vested on March 8, 2024. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 21:52 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | GrantCommon Stock | 124,826 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-030466 · ownership.xml · nonDerivative · entry 1 Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,700,306 F1 · shares: Includes 124,826 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 18:50 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | SaleCommon Stock | 115,136 | $8.02 | $923,390.72 |
DisclosureSEC source: 0000950170-24-025136 · ownership.xml · nonDerivative · entry 1 Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,575,480 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2022. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $8.00 to $8.25 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 16:05 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | SaleCommon Stock | 113,334 | $6.54 | $741,204.36 |
DisclosureSEC source: 0000950170-23-067737 · ownership.xml · nonDerivative · entry 1 Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,690,616 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2022. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $6.46 to $6.64 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 07, 2023 Filed Nov 8, 2023 18:23 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | SaleCommon Stock | 32,056 | $6.12 | $196,182.72 |
DisclosureSEC source: 0000950170-23-061332 · ownership.xml · nonDerivative · entry 2 Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,803,950 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2022. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $6.11 to $6.16 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 06, 2023 Filed Nov 8, 2023 18:23 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | SaleCommon Stock | 300 | $6.12 | $1,836.00 |
DisclosureSEC source: 0000950170-23-061332 · ownership.xml · nonDerivative · entry 1 Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,836,006 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2022. Read SEC document |
| November 03, 2023 Filed Nov 6, 2023 16:30 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | SaleCommon Stock | 80,977 | $6.13 | $496,389.01 |
DisclosureSEC source: 0000950170-23-059447 · ownership.xml · nonDerivative · entry 1 Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,836,306 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2022. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $6.11 to $6.18 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| October 02, 2023 Filed Oct 3, 2023 16:30 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | SaleCommon Stock | 113,333 | $6.61 | $749,131.13 |
DisclosureSEC source: 0000950170-23-051565 · ownership.xml · nonDerivative · entry 1 Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,917,283 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2022. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $6.50 to $6.81 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 06, 2023 Filed Jul 7, 2023 17:27 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | SaleCommon Stock | 135,400 | $8.67 | $1,173,918.00 |
DisclosureSEC source: 0000950170-23-032287 · ownership.xml · nonDerivative · entry 1 Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,030,616 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2022. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $8.31 to $8.97 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 05, 2023 Filed Jul 6, 2023 16:30 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | SaleCommon Stock | 150,000 | $8.72 | $1,308,000.00 |
DisclosureSEC source: 0000950170-23-032034 · ownership.xml · nonDerivative · entry 2 Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,166,016 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2022. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $8.63 to $8.96 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 03, 2023 Filed Jul 6, 2023 16:30 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | SaleCommon Stock | 54,600 | $9.00 | $491,400.00 |
DisclosureSEC source: 0000950170-23-032034 · ownership.xml · nonDerivative · entry 1 Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,316,016 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2022. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $8.91 to $9.13 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| June 23, 2023 Filed Jun 27, 2023 16:41 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | SaleCommon Stock | 65,832 | $9.02 | $593,804.64 |
DisclosureSEC source: 0000950170-23-030155 · ownership.xml · nonDerivative · entry 1 Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,370,616 F1 · kind: Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $8.97 to $9.10 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 04, 2023 Filed Apr 6, 2023 17:10 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | SaleCommon Stock | 69,734 | $7.61 | $530,675.74 |
DisclosureSEC source: 0000899243-23-010874 · doc4.xml · nonDerivative · entry 1 Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,436,448 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2022. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.46 to $7.77 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 04, 2023 Filed Apr 6, 2023 17:00 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | SaleCommon Stock | 6,399 | $7.62 | $48,760.38 |
DisclosureSEC source: 0000899243-23-010864 · doc4.xml · nonDerivative · entry 1 Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,506,182 F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| April 03, 2023 Filed Apr 4, 2023 20:00 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | SaleCommon Stock | 97,266 | $7.43 | $722,686.38 |
DisclosureSEC source: 0000899243-23-010555 · doc4.xml · nonDerivative · entry 1 Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,512,581 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2022. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.17 to $7.53 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 16, 2023 Filed Mar 17, 2023 16:30 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | SaleCommon Stock | 43,705 | $6.14 | $268,348.70 |
DisclosureSEC source: 0000899243-23-008876 · doc4.xml · nonDerivative · entry 2 Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,609,847 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $6.11 to $6.23 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 16:30 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | SaleCommon Stock | 200 | $6.11 | $1,222.00 |
DisclosureSEC source: 0000899243-23-008876 · doc4.xml · nonDerivative · entry 1 Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,653,552 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 17:51 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | SaleCommon Stock | 800 | $6.11 | $4,888.00 |
DisclosureSEC source: 0000899243-23-008603 · doc4.xml · nonDerivative · entry 1 Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,653,752 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 17:00 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | SaleCommon Stock | 122,295 | $6.12 | $748,445.40 |
DisclosureSEC source: 0000899243-23-008136 · doc4.xml · nonDerivative · entry 1 Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,654,552 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $6.11 to $6.22 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 17:19 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | GrantCommon Stock | 192,307 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007559 · doc4.xml · nonDerivative · entry 1 Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,776,847 F1 · shares: Includes 192,307 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| September 30, 2022 Filed Oct 3, 2022 16:33 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | SaleCommon Stock | 82,520 | $7.03 | $580,115.60 |
DisclosureSEC source: 0000899243-22-032431 · doc4.xml · nonDerivative · entry 1 Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,584,540 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.00 to $7.20 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| June 13, 2022 Filed Jun 14, 2022 16:43 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | SaleCommon Stock | 78,858 | $5.30 | $417,947.40 |
DisclosureSEC source: 0000899243-22-022399 · doc4.xml · nonDerivative · entry 1 Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,667,060 F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| April 25, 2022 Filed Apr 26, 2022 17:14 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | GrantCommon Stock | 76,446 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-015669 · doc4.xml · nonDerivative · entry 1 Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,745,918 F1 · shares: Includes 76,446 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| April 20, 2022 Filed Apr 22, 2022 18:00 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | SaleCommon Stock | 46,283 | $10.68 | $494,302.44 |
DisclosureSEC source: 0000899243-22-015505 · doc4.xml · nonDerivative · entry 1 Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,669,472 F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $10.15 to $10.99, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.